Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.42940673 |
2 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.19672690 |
3 | locomotory exploration behavior (GO:0035641) | 5.19145716 |
4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.16093429 |
5 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.92835528 |
6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.73138788 |
7 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.60866338 |
8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.57548650 |
9 | B cell receptor signaling pathway (GO:0050853) | 4.51562336 |
10 | synaptic vesicle maturation (GO:0016188) | 4.40873486 |
11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.31113048 |
12 | cellular response to ethanol (GO:0071361) | 4.24620871 |
13 | vocalization behavior (GO:0071625) | 4.20191673 |
14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.16103119 |
15 | positive T cell selection (GO:0043368) | 4.05973183 |
16 | glutamate receptor signaling pathway (GO:0007215) | 4.03709971 |
17 | negative T cell selection (GO:0043383) | 4.00602036 |
18 | negative thymic T cell selection (GO:0045060) | 4.00301272 |
19 | positive regulation of granulocyte differentiation (GO:0030854) | 3.97245896 |
20 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.96568268 |
21 | synaptic vesicle exocytosis (GO:0016079) | 3.96063866 |
22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.94266937 |
23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.94091048 |
24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.90402592 |
25 | exploration behavior (GO:0035640) | 3.87573039 |
26 | histone H3-K36 demethylation (GO:0070544) | 3.81244023 |
27 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.79459533 |
28 | protein localization to synapse (GO:0035418) | 3.78981347 |
29 | synaptic transmission, glutamatergic (GO:0035249) | 3.74590102 |
30 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.73966808 |
31 | glutamate secretion (GO:0014047) | 3.65135290 |
32 | neuron cell-cell adhesion (GO:0007158) | 3.65054271 |
33 | nerve growth factor signaling pathway (GO:0038180) | 3.54949016 |
34 | positive thymic T cell selection (GO:0045059) | 3.50956480 |
35 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.48685754 |
36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.47767361 |
37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.46843153 |
38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.44557139 |
39 | cellular potassium ion homeostasis (GO:0030007) | 3.42281621 |
40 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.42149955 |
41 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.41162146 |
42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41031077 |
43 | neuron-neuron synaptic transmission (GO:0007270) | 3.40295348 |
44 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.38839269 |
45 | regulation of synaptic vesicle transport (GO:1902803) | 3.37305417 |
46 | neurotransmitter secretion (GO:0007269) | 3.36527557 |
47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.35167066 |
48 | long-term memory (GO:0007616) | 3.34978325 |
49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33516154 |
50 | interkinetic nuclear migration (GO:0022027) | 3.32700534 |
51 | layer formation in cerebral cortex (GO:0021819) | 3.32040887 |
52 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.31265764 |
53 | neuronal action potential propagation (GO:0019227) | 3.30699228 |
54 | regulation of ARF protein signal transduction (GO:0032012) | 3.28350940 |
55 | T cell selection (GO:0045058) | 3.24578959 |
56 | dendritic spine morphogenesis (GO:0060997) | 3.23288541 |
57 | gamma-aminobutyric acid transport (GO:0015812) | 3.22421352 |
58 | activation of protein kinase A activity (GO:0034199) | 3.22360370 |
59 | proline transport (GO:0015824) | 3.22336054 |
60 | cellular extravasation (GO:0045123) | 3.20957832 |
61 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.20687351 |
62 | microglial cell activation (GO:0001774) | 3.17625985 |
63 | membrane depolarization during action potential (GO:0086010) | 3.16054752 |
64 | peptidyl-lysine trimethylation (GO:0018023) | 3.16022113 |
65 | T cell migration (GO:0072678) | 3.15207337 |
66 | negative regulation of cell killing (GO:0031342) | 3.12466423 |
67 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.12466423 |
68 | regulation of synapse structural plasticity (GO:0051823) | 3.09845371 |
69 | synaptic vesicle endocytosis (GO:0048488) | 3.09762693 |
70 | positive regulation of Rap GTPase activity (GO:0032854) | 3.08942172 |
71 | activated T cell proliferation (GO:0050798) | 3.08647243 |
72 | dendrite morphogenesis (GO:0048813) | 3.08407840 |
73 | regulation of pigment cell differentiation (GO:0050932) | 3.07569248 |
74 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.06528845 |
75 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.05373093 |
76 | positive regulation of B cell differentiation (GO:0045579) | 3.04796028 |
77 | sodium ion export (GO:0071436) | 3.04460992 |
78 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.04359789 |
79 | response to interleukin-15 (GO:0070672) | 3.03826458 |
80 | phospholipid translocation (GO:0045332) | 3.03593479 |
81 | lipid translocation (GO:0034204) | 3.03593479 |
82 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.03424131 |
83 | neuron recognition (GO:0008038) | 3.01355411 |
84 | regulation of Rap GTPase activity (GO:0032317) | 3.00400068 |
85 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00105025 |
86 | B cell proliferation (GO:0042100) | 2.99414076 |
87 | membrane depolarization (GO:0051899) | 2.97916060 |
88 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.97656905 |
89 | vesicle transport along microtubule (GO:0047496) | 2.95608408 |
90 | positive regulation of membrane potential (GO:0045838) | 2.95418749 |
91 | regulation of B cell differentiation (GO:0045577) | 2.94964172 |
92 | presynaptic membrane assembly (GO:0097105) | 2.94775124 |
93 | transmission of nerve impulse (GO:0019226) | 2.94483196 |
94 | axonal fasciculation (GO:0007413) | 2.91617149 |
95 | thymic T cell selection (GO:0045061) | 2.90429417 |
96 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.90417481 |
97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.89537042 |
98 | prepulse inhibition (GO:0060134) | 2.88607303 |
99 | positive regulation of developmental pigmentation (GO:0048087) | 2.86678917 |
100 | response to histamine (GO:0034776) | 2.85319690 |
101 | peptidyl-threonine phosphorylation (GO:0018107) | 2.84889118 |
102 | establishment of nucleus localization (GO:0040023) | 2.84682407 |
103 | regulation of synaptic plasticity (GO:0048167) | 2.83947692 |
104 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.83148716 |
105 | nucleus localization (GO:0051647) | 2.82402669 |
106 | macrophage activation involved in immune response (GO:0002281) | 2.81594993 |
107 | regulation of vesicle fusion (GO:0031338) | 2.81395977 |
108 | nuclear pore complex assembly (GO:0051292) | 2.80030888 |
109 | neuromuscular process controlling balance (GO:0050885) | 2.79411411 |
110 | cellular response to interleukin-15 (GO:0071350) | 2.78956206 |
111 | hepatocyte apoptotic process (GO:0097284) | 2.78731768 |
112 | regulation of dendritic spine development (GO:0060998) | 2.77416038 |
113 | protein K48-linked deubiquitination (GO:0071108) | 2.77122981 |
114 | histone mRNA catabolic process (GO:0071044) | 2.76432958 |
115 | mature B cell differentiation (GO:0002335) | 2.75342940 |
116 | regulation of granulocyte differentiation (GO:0030852) | 2.74743753 |
117 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.74618055 |
118 | innervation (GO:0060384) | 2.73981065 |
119 | long-term synaptic potentiation (GO:0060291) | 2.73968483 |
120 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.73485754 |
121 | negative regulation of B cell proliferation (GO:0030889) | 2.73319857 |
122 | regulation of neurotransmitter secretion (GO:0046928) | 2.72138157 |
123 | membrane hyperpolarization (GO:0060081) | 2.71966792 |
124 | positive regulation of synapse maturation (GO:0090129) | 2.71752115 |
125 | neurotransmitter transport (GO:0006836) | 2.71712820 |
126 | presynaptic membrane organization (GO:0097090) | 2.71678723 |
127 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.71565413 |
128 | positive regulation of dendritic spine development (GO:0060999) | 2.70871778 |
129 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.70723304 |
130 | behavioral fear response (GO:0001662) | 2.70351852 |
131 | behavioral defense response (GO:0002209) | 2.70351852 |
132 | histone H3-K4 trimethylation (GO:0080182) | 2.70024491 |
133 | histone H3-K4 methylation (GO:0051568) | 2.69680991 |
134 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.68221338 |
135 | postsynaptic membrane organization (GO:0001941) | 2.68058948 |
136 | response to auditory stimulus (GO:0010996) | 2.67213132 |
137 | B cell homeostasis (GO:0001782) | 2.67206978 |
138 | histone H3-K9 demethylation (GO:0033169) | 2.66366255 |
139 | auditory behavior (GO:0031223) | 2.65777076 |
140 | cell communication by electrical coupling (GO:0010644) | 2.65750746 |
141 | establishment of protein localization to Golgi (GO:0072600) | 2.63532335 |
142 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62676273 |
143 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.62010988 |
144 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61381680 |
145 | startle response (GO:0001964) | 2.60291509 |
146 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.59997000 |
147 | organelle transport along microtubule (GO:0072384) | 2.59987258 |
148 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.59950147 |
149 | regulation of protein polyubiquitination (GO:1902914) | 2.59630049 |
150 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.59554800 |
151 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.58887853 |
152 | learning (GO:0007612) | 2.58262456 |
153 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.56605384 |
154 | cell differentiation in hindbrain (GO:0021533) | 2.56555892 |
155 | peptidyl-threonine modification (GO:0018210) | 2.56479144 |
156 | L-amino acid import (GO:0043092) | 2.56466557 |
157 | peptidyl-lysine methylation (GO:0018022) | 2.56172432 |
158 | protein targeting to Golgi (GO:0000042) | 2.55056155 |
159 | fear response (GO:0042596) | 2.53313080 |
160 | modulation by symbiont of host immune response (GO:0052553) | 2.53254148 |
161 | positive regulation by symbiont of host defense response (GO:0052509) | 2.53254148 |
162 | modulation by symbiont of host defense response (GO:0052031) | 2.53254148 |
163 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.53254148 |
164 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.53254148 |
165 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.53254148 |
166 | regulation of neurotransmitter levels (GO:0001505) | 2.52974721 |
167 | glycine transport (GO:0015816) | 2.52699691 |
168 | suckling behavior (GO:0001967) | 2.52576292 |
169 | histone lysine methylation (GO:0034968) | 2.51191231 |
170 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.48629783 |
171 | histone H3-K9 modification (GO:0061647) | 2.48308256 |
172 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.47900115 |
173 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.47673254 |
174 | germinal center formation (GO:0002467) | 2.47175444 |
175 | negative regulation of neurotransmitter transport (GO:0051589) | 2.46976033 |
176 | corticosteroid receptor signaling pathway (GO:0031958) | 2.46322244 |
177 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.45441472 |
178 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.43972721 |
179 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.43944913 |
180 | macrophage activation (GO:0042116) | 2.43275881 |
181 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.42641339 |
182 | regulation of histone H3-K27 methylation (GO:0061085) | 2.42314511 |
183 | negative regulation of adaptive immune response (GO:0002820) | 2.41070497 |
184 | peptidyl-serine phosphorylation (GO:0018105) | 2.40754662 |
185 | detection of molecule of bacterial origin (GO:0032490) | 2.40247827 |
186 | phosphatidylinositol phosphorylation (GO:0046854) | 2.40245490 |
187 | myeloid leukocyte mediated immunity (GO:0002444) | 2.39020815 |
188 | histone lysine demethylation (GO:0070076) | 2.38277553 |
189 | regulation of B cell proliferation (GO:0030888) | 2.37683158 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.06737105 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.56620946 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.32913121 |
4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.48063710 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.40419800 |
6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39326803 |
7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.38974262 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.38272368 |
9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.34087622 |
10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.13783810 |
11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.13491718 |
12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.10844788 |
13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.10338981 |
14 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.08641400 |
15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.05882374 |
16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.05618210 |
17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.04531563 |
18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.03974021 |
19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.03974021 |
20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.03759726 |
21 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.97203802 |
22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93902150 |
23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92126381 |
24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.91054602 |
25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.88654524 |
26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88290400 |
27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.87727305 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81664983 |
29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81438662 |
30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80864168 |
31 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79656591 |
32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77191577 |
33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75046575 |
34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74911937 |
35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.73956224 |
36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70793932 |
37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70749451 |
38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.68673601 |
39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.66138933 |
40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65749188 |
41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.65391112 |
42 | * MYB_26560356_Chip-Seq_TH2_Human | 1.64328766 |
43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.63433323 |
44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62462527 |
45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.61224275 |
46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.60318705 |
47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57607788 |
48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.57452960 |
49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.53109641 |
50 | TP53_16413492_ChIP-PET_HCT116_Human | 1.52987044 |
51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51533783 |
52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.51064151 |
53 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.51011184 |
54 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50494581 |
55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48770137 |
56 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48338607 |
57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.48211145 |
58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45974381 |
59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45788133 |
60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44613021 |
61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41950496 |
62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41428234 |
63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40685526 |
64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40601298 |
65 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.40540196 |
66 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.39458297 |
67 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37319341 |
68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36613859 |
69 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35781585 |
70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.34468079 |
71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34263289 |
72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32645088 |
73 | * MYB_26560356_Chip-Seq_TH1_Human | 1.32092473 |
74 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31137616 |
75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30390499 |
76 | * AR_19668381_ChIP-Seq_PC3_Human | 1.30110027 |
77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28712969 |
78 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28593302 |
79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28570802 |
80 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27878795 |
81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.27878795 |
82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26710287 |
83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23548304 |
84 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23196172 |
85 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23042287 |
86 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22579123 |
87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22578343 |
88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22206795 |
89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22203282 |
90 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19493316 |
91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17824988 |
92 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16391357 |
93 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15927628 |
94 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14324366 |
95 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.13574352 |
96 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12848298 |
97 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11939864 |
98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11755960 |
99 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10384597 |
100 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.09922530 |
101 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09559424 |
102 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08831502 |
103 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08788715 |
104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07965374 |
105 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07763618 |
106 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06031618 |
107 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04956662 |
108 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04549676 |
109 | * MYC_22102868_ChIP-Seq_BL_Human | 1.04195614 |
110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03833990 |
111 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03798097 |
112 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03257766 |
113 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02562217 |
114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02328437 |
115 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02185688 |
116 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01804032 |
117 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01470799 |
118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01429387 |
119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01276639 |
120 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01258994 |
121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00620934 |
122 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99722020 |
123 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99262679 |
124 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99082802 |
125 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98769306 |
126 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98585887 |
127 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98268602 |
128 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97975017 |
129 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97780585 |
130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97073774 |
131 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96957575 |
132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96641142 |
133 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95671033 |
134 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95305284 |
135 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.95115615 |
136 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95109266 |
137 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94941231 |
138 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94759611 |
139 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94601604 |
140 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92656886 |
141 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92459412 |
142 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92318831 |
143 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92277752 |
144 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91650220 |
145 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91581473 |
146 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91531486 |
147 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91308406 |
148 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90990102 |
149 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90325312 |
150 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90024523 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.44269487 |
2 | MP0008057_abnormal_DNA_replication | 4.96315947 |
3 | MP0003880_abnormal_central_pattern | 4.15827700 |
4 | MP0000569_abnormal_digit_pigmentation | 4.14016021 |
5 | MP0003635_abnormal_synaptic_transmissio | 3.87785251 |
6 | MP0003763_abnormal_thymus_physiology | 3.54743078 |
7 | MP0009745_abnormal_behavioral_response | 3.18456923 |
8 | MP0004270_analgesia | 3.10096285 |
9 | MP0002063_abnormal_learning/memory/cond | 3.02728922 |
10 | MP0009046_muscle_twitch | 2.96098456 |
11 | MP0001835_abnormal_antigen_presentation | 2.93515907 |
12 | MP0002064_seizures | 2.80404745 |
13 | MP0001968_abnormal_touch/_nociception | 2.78439012 |
14 | MP0005423_abnormal_somatic_nervous | 2.62562078 |
15 | MP0003787_abnormal_imprinting | 2.60346674 |
16 | MP0002572_abnormal_emotion/affect_behav | 2.59149417 |
17 | MP0001486_abnormal_startle_reflex | 2.39962301 |
18 | MP0002396_abnormal_hematopoietic_system | 2.38993080 |
19 | MP0002735_abnormal_chemical_nociception | 2.37493448 |
20 | MP0001501_abnormal_sleep_pattern | 2.35560691 |
21 | MP0002272_abnormal_nervous_system | 2.28556101 |
22 | MP0001800_abnormal_humoral_immune | 2.25408968 |
23 | MP0004381_abnormal_hair_follicle | 2.24155451 |
24 | MP0002734_abnormal_mechanical_nocicepti | 2.17408471 |
25 | MP0008569_lethality_at_weaning | 2.05947788 |
26 | MP0002736_abnormal_nociception_after | 2.02261422 |
27 | MP0002067_abnormal_sensory_capabilities | 1.97074264 |
28 | MP0001440_abnormal_grooming_behavior | 1.93442901 |
29 | MP0000685_abnormal_immune_system | 1.87645585 |
30 | MP0009780_abnormal_chondrocyte_physiolo | 1.84960940 |
31 | MP0002909_abnormal_adrenal_gland | 1.75940273 |
32 | MP0005671_abnormal_response_to | 1.73869980 |
33 | MP0002822_catalepsy | 1.73162718 |
34 | MP0002733_abnormal_thermal_nociception | 1.72409621 |
35 | MP0002398_abnormal_bone_marrow | 1.67393429 |
36 | MP0002006_tumorigenesis | 1.66279533 |
37 | MP0001970_abnormal_pain_threshold | 1.65573479 |
38 | MP0005386_behavior/neurological_phenoty | 1.64079769 |
39 | MP0004924_abnormal_behavior | 1.64079769 |
40 | MP0004808_abnormal_hematopoietic_stem | 1.63752610 |
41 | MP0002557_abnormal_social/conspecific_i | 1.61823441 |
42 | MP0004811_abnormal_neuron_physiology | 1.60256116 |
43 | * MP0000778_abnormal_nervous_system | 1.59242005 |
44 | MP0002420_abnormal_adaptive_immunity | 1.58570255 |
45 | MP0004510_myositis | 1.57419489 |
46 | MP0003045_fibrosis | 1.56347104 |
47 | * MP0002184_abnormal_innervation | 1.56121530 |
48 | MP0000703_abnormal_thymus_morphology | 1.54355186 |
49 | MP0005000_abnormal_immune_tolerance | 1.53752131 |
50 | MP0001819_abnormal_immune_cell | 1.53450769 |
51 | MP0005645_abnormal_hypothalamus_physiol | 1.52845167 |
52 | MP0001790_abnormal_immune_system | 1.52793233 |
53 | MP0005387_immune_system_phenotype | 1.52793233 |
54 | MP0002723_abnormal_immune_serum | 1.52572915 |
55 | MP0002452_abnormal_antigen_presenting | 1.49260633 |
56 | MP0001188_hyperpigmentation | 1.43409410 |
57 | MP0005646_abnormal_pituitary_gland | 1.43023566 |
58 | MP0000716_abnormal_immune_system | 1.39094974 |
59 | MP0003633_abnormal_nervous_system | 1.36180179 |
60 | MP0008961_abnormal_basal_metabolism | 1.35289906 |
61 | MP0001502_abnormal_circadian_rhythm | 1.35214705 |
62 | MP0001984_abnormal_olfaction | 1.32210548 |
63 | MP0003091_abnormal_cell_migration | 1.29514575 |
64 | MP0003724_increased_susceptibility_to | 1.28768359 |
65 | MP0004858_abnormal_nervous_system | 1.28343997 |
66 | * MP0000955_abnormal_spinal_cord | 1.27105205 |
67 | MP0008877_abnormal_DNA_methylation | 1.25098868 |
68 | * MP0002882_abnormal_neuron_morphology | 1.23776897 |
69 | MP0004885_abnormal_endolymph | 1.23754989 |
70 | MP0003879_abnormal_hair_cell | 1.23433828 |
71 | MP0003866_abnormal_defecation | 1.23028586 |
72 | MP0006276_abnormal_autonomic_nervous | 1.22742988 |
73 | MP0000689_abnormal_spleen_morphology | 1.21388056 |
74 | MP0010352_gastrointestinal_tract_polyps | 1.18870580 |
75 | * MP0002066_abnormal_motor_capabilities/c | 1.18812686 |
76 | MP0002419_abnormal_innate_immunity | 1.18112021 |
77 | MP0002722_abnormal_immune_system | 1.17880328 |
78 | MP0003183_abnormal_peptide_metabolism | 1.17200215 |
79 | MP0003828_pulmonary_edema | 1.16812239 |
80 | MP0002405_respiratory_system_inflammati | 1.16535879 |
81 | MP0005075_abnormal_melanosome_morpholog | 1.14773696 |
82 | MP0005174_abnormal_tail_pigmentation | 1.13980283 |
83 | MP0008260_abnormal_autophagy | 1.12138482 |
84 | MP0005025_abnormal_response_to | 1.11509263 |
85 | MP0005409_darkened_coat_color | 1.09210548 |
86 | MP0003172_abnormal_lysosome_physiology | 1.08617017 |
87 | MP0001851_eye_inflammation | 1.08553364 |
88 | MP0005464_abnormal_platelet_physiology | 1.07129288 |
89 | MP0003122_maternal_imprinting | 1.07128318 |
90 | MP0000015_abnormal_ear_pigmentation | 1.05219582 |
91 | MP0004947_skin_inflammation | 1.04805191 |
92 | MP0004145_abnormal_muscle_electrophysio | 1.04426960 |
93 | MP0003436_decreased_susceptibility_to | 1.03331173 |
94 | * MP0003631_nervous_system_phenotype | 1.03033347 |
95 | MP0003690_abnormal_glial_cell | 1.00185564 |
96 | MP0002429_abnormal_blood_cell | 0.99945110 |
97 | MP0004742_abnormal_vestibular_system | 0.98426227 |
98 | * MP0002152_abnormal_brain_morphology | 0.97522742 |
99 | MP0009115_abnormal_fat_cell | 0.93457378 |
100 | MP0000371_diluted_coat_color | 0.92453696 |
101 | MP0000465_gastrointestinal_hemorrhage | 0.90896262 |
102 | MP0002229_neurodegeneration | 0.90421438 |
103 | MP0003868_abnormal_feces_composition | 0.90255140 |
104 | MP0005551_abnormal_eye_electrophysiolog | 0.88593454 |
105 | MP0003329_amyloid_beta_deposits | 0.87843720 |
106 | MP0008874_decreased_physiological_sensi | 0.84800436 |
107 | MP0001177_atelectasis | 0.82105519 |
108 | MP0004883_abnormal_blood_vessel | 0.81290017 |
109 | MP0004142_abnormal_muscle_tone | 0.80429666 |
110 | MP0002332_abnormal_exercise_endurance | 0.79759358 |
111 | MP0005076_abnormal_cell_differentiation | 0.79601681 |
112 | MP0002069_abnormal_eating/drinking_beha | 0.78908458 |
113 | MP0002090_abnormal_vision | 0.78854404 |
114 | MP0001299_abnormal_eye_distance/ | 0.78828289 |
115 | MP0004130_abnormal_muscle_cell | 0.78734077 |
116 | MP0005621_abnormal_cell_physiology | 0.77899891 |
117 | MP0003121_genomic_imprinting | 0.77436202 |
118 | MP0010386_abnormal_urinary_bladder | 0.73337096 |
119 | MP0000427_abnormal_hair_cycle | 0.72566669 |
120 | MP0000604_amyloidosis | 0.72183178 |
121 | MP0004484_altered_response_of | 0.71582650 |
122 | MP0003303_peritoneal_inflammation | 0.71166347 |
123 | MP0001986_abnormal_taste_sensitivity | 0.69212550 |
124 | MP0002095_abnormal_skin_pigmentation | 0.68929300 |
125 | MP0002998_abnormal_bone_remodeling | 0.68315287 |
126 | MP0002876_abnormal_thyroid_physiology | 0.67769847 |
127 | MP0003634_abnormal_glial_cell | 0.67591259 |
128 | MP0005397_hematopoietic_system_phenotyp | 0.67420281 |
129 | MP0001545_abnormal_hematopoietic_system | 0.67420281 |
130 | MP0005535_abnormal_body_temperature | 0.67310452 |
131 | MP0003656_abnormal_erythrocyte_physiolo | 0.66868942 |
132 | MP0004134_abnormal_chest_morphology | 0.66093856 |
133 | MP0000751_myopathy | 0.65569604 |
134 | MP0008872_abnormal_physiological_respon | 0.65383016 |
135 | MP0010155_abnormal_intestine_physiology | 0.63002422 |
136 | * MP0003632_abnormal_nervous_system | 0.62568633 |
137 | MP0000920_abnormal_myelination | 0.62374433 |
138 | MP0004085_abnormal_heartbeat | 0.61990256 |
139 | MP0005310_abnormal_salivary_gland | 0.61989415 |
140 | MP0001963_abnormal_hearing_physiology | 0.58493768 |
141 | MP0001905_abnormal_dopamine_level | 0.57086790 |
142 | MP0002166_altered_tumor_susceptibility | 0.56222077 |
143 | MP0010769_abnormal_survival | 0.54865604 |
144 | MP0000631_abnormal_neuroendocrine_gland | 0.54753088 |
145 | MP0002082_postnatal_lethality | 0.52772662 |
146 | MP0010770_preweaning_lethality | 0.52772662 |
147 | MP0010768_mortality/aging | 0.51920950 |
148 | MP0010234_abnormal_vibrissa_follicle | 0.50808250 |
149 | * MP0002752_abnormal_somatic_nervous | 0.50724602 |
150 | MP0000013_abnormal_adipose_tissue | 0.50440586 |
151 | MP0004215_abnormal_myocardial_fiber | 0.47905669 |
152 | MP0002009_preneoplasia | 0.47298168 |
153 | MP0003300_gastrointestinal_ulcer | 0.47187252 |
154 | MP0005670_abnormal_white_adipose | 0.46701555 |
155 | MP0003075_altered_response_to | 0.46654696 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.08718267 |
2 | Focal seizures (HP:0007359) | 4.84926797 |
3 | Febrile seizures (HP:0002373) | 4.39686916 |
4 | Myokymia (HP:0002411) | 4.27394254 |
5 | T lymphocytopenia (HP:0005403) | 4.16670780 |
6 | Visual hallucinations (HP:0002367) | 4.00561597 |
7 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.86592314 |
8 | Progressive cerebellar ataxia (HP:0002073) | 3.85428103 |
9 | Abnormality of T cell number (HP:0011839) | 3.82826203 |
10 | Epileptic encephalopathy (HP:0200134) | 3.62570870 |
11 | Action tremor (HP:0002345) | 3.58579428 |
12 | Atonic seizures (HP:0010819) | 3.49973178 |
13 | Broad-based gait (HP:0002136) | 3.44240212 |
14 | Gaze-evoked nystagmus (HP:0000640) | 3.40984182 |
15 | Papillary thyroid carcinoma (HP:0002895) | 3.29788129 |
16 | Absence seizures (HP:0002121) | 3.13203501 |
17 | Colitis (HP:0002583) | 3.10388022 |
18 | Genetic anticipation (HP:0003743) | 3.09265654 |
19 | Recurrent viral infections (HP:0004429) | 3.03656704 |
20 | Supranuclear gaze palsy (HP:0000605) | 2.97967848 |
21 | Truncal ataxia (HP:0002078) | 2.96549198 |
22 | Recurrent bacterial skin infections (HP:0005406) | 2.96492717 |
23 | Postural instability (HP:0002172) | 2.94934453 |
24 | Dialeptic seizures (HP:0011146) | 2.93439843 |
25 | Macroorchidism (HP:0000053) | 2.89545115 |
26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.86980974 |
27 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.84712834 |
28 | Dysdiadochokinesis (HP:0002075) | 2.83626010 |
29 | Generalized tonic-clonic seizures (HP:0002069) | 2.81533766 |
30 | Recurrent fungal infections (HP:0002841) | 2.80232090 |
31 | Eczematoid dermatitis (HP:0000976) | 2.79808291 |
32 | Excessive salivation (HP:0003781) | 2.77959926 |
33 | Drooling (HP:0002307) | 2.77959926 |
34 | Hemiplegia (HP:0002301) | 2.76246135 |
35 | Impaired smooth pursuit (HP:0007772) | 2.76242285 |
36 | Subacute progressive viral hepatitis (HP:0006572) | 2.72358990 |
37 | Poor eye contact (HP:0000817) | 2.71454650 |
38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.70817840 |
39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.70817840 |
40 | Acute myeloid leukemia (HP:0004808) | 2.68017786 |
41 | Progressive inability to walk (HP:0002505) | 2.65966094 |
42 | Agammaglobulinemia (HP:0004432) | 2.65243781 |
43 | Papilledema (HP:0001085) | 2.64868592 |
44 | Viral hepatitis (HP:0006562) | 2.63867286 |
45 | Spontaneous hematomas (HP:0007420) | 2.60321161 |
46 | Dysmetria (HP:0001310) | 2.59862586 |
47 | Abnormal social behavior (HP:0012433) | 2.58093490 |
48 | Impaired social interactions (HP:0000735) | 2.58093490 |
49 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.57773419 |
50 | Hypoplasia of the thymus (HP:0000778) | 2.57307250 |
51 | Panhypogammaglobulinemia (HP:0003139) | 2.55277283 |
52 | Recurrent bronchitis (HP:0002837) | 2.52077276 |
53 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.51855612 |
54 | Depression (HP:0000716) | 2.50079724 |
55 | Scanning speech (HP:0002168) | 2.49160882 |
56 | Abnormality of binocular vision (HP:0011514) | 2.47901335 |
57 | Diplopia (HP:0000651) | 2.47901335 |
58 | Inappropriate behavior (HP:0000719) | 2.45651843 |
59 | Autoimmune hemolytic anemia (HP:0001890) | 2.43494998 |
60 | Truncal obesity (HP:0001956) | 2.41940763 |
61 | Thyroiditis (HP:0100646) | 2.41804137 |
62 | Abnormality of T cells (HP:0002843) | 2.41444231 |
63 | Inflammation of the large intestine (HP:0002037) | 2.39745727 |
64 | Dysmetric saccades (HP:0000641) | 2.39224901 |
65 | Exotropia (HP:0000577) | 2.37325008 |
66 | Intention tremor (HP:0002080) | 2.36816927 |
67 | IgA deficiency (HP:0002720) | 2.36686626 |
68 | Slow saccadic eye movements (HP:0000514) | 2.35484926 |
69 | Recurrent abscess formation (HP:0002722) | 2.34996600 |
70 | Ankle clonus (HP:0011448) | 2.32850912 |
71 | Prominent nose (HP:0000448) | 2.32085100 |
72 | Absent speech (HP:0001344) | 2.31033997 |
73 | Abnormality of the fingertips (HP:0001211) | 2.28856140 |
74 | Meningitis (HP:0001287) | 2.28659534 |
75 | Overgrowth (HP:0001548) | 2.28583299 |
76 | Lower limb amyotrophy (HP:0007210) | 2.27475767 |
77 | Protruding tongue (HP:0010808) | 2.27139617 |
78 | Urinary urgency (HP:0000012) | 2.25012784 |
79 | Mutism (HP:0002300) | 2.24823842 |
80 | Aqueductal stenosis (HP:0002410) | 2.24271305 |
81 | Gastrointestinal inflammation (HP:0004386) | 2.22936354 |
82 | Recurrent skin infections (HP:0001581) | 2.22489401 |
83 | Submucous cleft hard palate (HP:0000176) | 2.22434619 |
84 | Conjunctival telangiectasia (HP:0000524) | 2.22379917 |
85 | Gingivitis (HP:0000230) | 2.20398628 |
86 | Stereotypic behavior (HP:0000733) | 2.20035925 |
87 | Hemiparesis (HP:0001269) | 2.15310902 |
88 | Hyperventilation (HP:0002883) | 2.14975101 |
89 | Volvulus (HP:0002580) | 2.13242121 |
90 | Widely spaced teeth (HP:0000687) | 2.13181565 |
91 | Cellulitis (HP:0100658) | 2.11702800 |
92 | Open mouth (HP:0000194) | 2.08042925 |
93 | Abnormal eating behavior (HP:0100738) | 2.07807201 |
94 | Chest pain (HP:0100749) | 2.06362357 |
95 | Spastic gait (HP:0002064) | 2.06250355 |
96 | Vasculitis (HP:0002633) | 2.04198098 |
97 | Short chin (HP:0000331) | 2.04088102 |
98 | Narrow palate (HP:0000189) | 2.04083837 |
99 | Neonatal hypoglycemia (HP:0001998) | 2.03798411 |
100 | Bundle branch block (HP:0011710) | 2.02667844 |
101 | Bradykinesia (HP:0002067) | 2.02476091 |
102 | Amblyopia (HP:0000646) | 1.99357402 |
103 | Menstrual irregularities (HP:0000858) | 1.99330968 |
104 | Pointed chin (HP:0000307) | 1.98393455 |
105 | Sandal gap (HP:0001852) | 1.97864645 |
106 | Tapered finger (HP:0001182) | 1.97592404 |
107 | Lower limb asymmetry (HP:0100559) | 1.96265055 |
108 | IgM deficiency (HP:0002850) | 1.95627438 |
109 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95357602 |
110 | Inability to walk (HP:0002540) | 1.94406205 |
111 | Abnormality of the lower motor neuron (HP:0002366) | 1.93387043 |
112 | Generalized hypopigmentation of hair (HP:0011358) | 1.92765874 |
113 | Abnormality of the corticospinal tract (HP:0002492) | 1.92319903 |
114 | Acute lymphatic leukemia (HP:0006721) | 1.91245536 |
115 | Lymphopenia (HP:0001888) | 1.90494447 |
116 | Abnormality of salivation (HP:0100755) | 1.90228364 |
117 | Agitation (HP:0000713) | 1.89372735 |
118 | Mediastinal lymphadenopathy (HP:0100721) | 1.88452553 |
119 | Blue irides (HP:0000635) | 1.87269694 |
120 | Thyroid carcinoma (HP:0002890) | 1.86707413 |
121 | Anxiety (HP:0000739) | 1.85904703 |
122 | Gingival bleeding (HP:0000225) | 1.85706027 |
123 | Verrucae (HP:0200043) | 1.85446109 |
124 | Papilloma (HP:0012740) | 1.85446109 |
125 | Absent frontal sinuses (HP:0002688) | 1.85141920 |
126 | Gastrointestinal infarctions (HP:0005244) | 1.85042952 |
127 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.84192217 |
128 | Eosinophilia (HP:0001880) | 1.82709994 |
129 | Termporal pattern (HP:0011008) | 1.81955190 |
130 | Insidious onset (HP:0003587) | 1.81955190 |
131 | Obsessive-compulsive behavior (HP:0000722) | 1.79802474 |
132 | Obstructive sleep apnea (HP:0002870) | 1.79710174 |
133 | Lower limb muscle weakness (HP:0007340) | 1.79619215 |
134 | Deeply set eye (HP:0000490) | 1.78625162 |
135 | Leukocytosis (HP:0001974) | 1.78037333 |
136 | Difficulty running (HP:0009046) | 1.76759314 |
137 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.76686258 |
138 | Increased IgE level (HP:0003212) | 1.76598767 |
139 | Thoracolumbar scoliosis (HP:0002944) | 1.76341492 |
140 | Severe combined immunodeficiency (HP:0004430) | 1.76246362 |
141 | Epileptiform EEG discharges (HP:0011182) | 1.75398386 |
142 | Hyperkalemia (HP:0002153) | 1.75234013 |
143 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.74962903 |
144 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.74962903 |
145 | Impaired vibratory sensation (HP:0002495) | 1.74278913 |
146 | Mask-like facies (HP:0000298) | 1.68667262 |
147 | Abnormality of saccadic eye movements (HP:0000570) | 1.68312457 |
148 | Amyotrophic lateral sclerosis (HP:0007354) | 1.67856239 |
149 | Buphthalmos (HP:0000557) | 1.66074082 |
150 | EEG with generalized epileptiform discharges (HP:0011198) | 1.65018526 |
151 | Abnormal hair whorl (HP:0010721) | 1.64640050 |
152 | Annular pancreas (HP:0001734) | 1.64145015 |
153 | Fair hair (HP:0002286) | 1.61339984 |
154 | Hypoplasia of the brainstem (HP:0002365) | 1.61278009 |
155 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.61278009 |
156 | Gait ataxia (HP:0002066) | 1.59935721 |
157 | Neuronal loss in central nervous system (HP:0002529) | 1.59239353 |
158 | Psychosis (HP:0000709) | 1.58977700 |
159 | Hyperacusis (HP:0010780) | 1.58113536 |
160 | Type II lissencephaly (HP:0007260) | 1.57223853 |
161 | Autism (HP:0000717) | 1.56259120 |
162 | Insomnia (HP:0100785) | 1.54624654 |
163 | Macroglossia (HP:0000158) | 1.54452838 |
164 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.53125460 |
165 | Heterotopia (HP:0002282) | 1.52895408 |
166 | Abnormal EKG (HP:0003115) | 1.51703352 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.51029941 |
2 | EPHA4 | 3.14421992 |
3 | MAP3K9 | 2.86864941 |
4 | MARK1 | 2.79744538 |
5 | MAP3K4 | 2.74662944 |
6 | RIPK4 | 2.36370858 |
7 | NTRK2 | 2.22923976 |
8 | SIK2 | 2.15237378 |
9 | CAMK1G | 2.15121881 |
10 | PRPF4B | 1.96919125 |
11 | BLK | 1.96071974 |
12 | TNIK | 1.94608132 |
13 | AKT3 | 1.93460494 |
14 | MAP2K7 | 1.92859880 |
15 | MAP4K1 | 1.91389017 |
16 | MINK1 | 1.79177235 |
17 | CAMKK1 | 1.72500002 |
18 | MAP3K13 | 1.70829231 |
19 | DAPK2 | 1.69320730 |
20 | MAPK13 | 1.60643132 |
21 | PAK6 | 1.59563743 |
22 | TAOK3 | 1.59249900 |
23 | NLK | 1.58100137 |
24 | BRD4 | 1.55756058 |
25 | CAMK1D | 1.55512527 |
26 | BTK | 1.54064568 |
27 | TEC | 1.53922282 |
28 | SGK2 | 1.48765334 |
29 | CAMKK2 | 1.47328524 |
30 | MAP2K4 | 1.44585419 |
31 | MAP3K10 | 1.43090289 |
32 | FES | 1.41586942 |
33 | TYK2 | 1.40259317 |
34 | SGK3 | 1.36632902 |
35 | IKBKE | 1.34248776 |
36 | BMPR2 | 1.33869112 |
37 | CDK5 | 1.28526300 |
38 | STK38 | 1.27701775 |
39 | TRPM7 | 1.26391986 |
40 | JAK3 | 1.22293369 |
41 | PNCK | 1.19563252 |
42 | PRKCH | 1.17964072 |
43 | TXK | 1.17566614 |
44 | ITK | 1.17535825 |
45 | CASK | 1.16703392 |
46 | PRKD3 | 1.16174691 |
47 | MARK2 | 1.14882479 |
48 | STK11 | 1.11347471 |
49 | NTRK1 | 1.10386965 |
50 | SGK494 | 1.07454321 |
51 | SGK223 | 1.07454321 |
52 | MAP3K12 | 1.07446225 |
53 | TNK2 | 1.07062915 |
54 | KSR1 | 1.06795950 |
55 | KSR2 | 1.06699563 |
56 | SGK1 | 1.05021219 |
57 | EEF2K | 1.03618205 |
58 | MELK | 1.02704884 |
59 | WNK1 | 1.01780854 |
60 | CSK | 0.99366236 |
61 | KIT | 0.99187123 |
62 | MAP3K2 | 0.99119641 |
63 | RET | 0.98325575 |
64 | DAPK1 | 0.97870925 |
65 | JAK1 | 0.97422652 |
66 | TAOK1 | 0.96465075 |
67 | CDC42BPA | 0.92320213 |
68 | JAK2 | 0.91215733 |
69 | PRKD2 | 0.90653385 |
70 | CAMK1 | 0.87420354 |
71 | MAPK11 | 0.85448936 |
72 | RIPK1 | 0.85329374 |
73 | LCK | 0.83331955 |
74 | FGFR3 | 0.83166901 |
75 | TYRO3 | 0.82382037 |
76 | PRKCG | 0.79984677 |
77 | PHKG1 | 0.79959868 |
78 | PHKG2 | 0.79959868 |
79 | CDK6 | 0.78835785 |
80 | FGFR2 | 0.77375443 |
81 | PDK1 | 0.75336256 |
82 | NEK6 | 0.74267286 |
83 | FGFR4 | 0.74152107 |
84 | CAMK2A | 0.72802419 |
85 | GRK6 | 0.72018261 |
86 | MAPK7 | 0.71160505 |
87 | EPHA3 | 0.70572111 |
88 | LYN | 0.70317863 |
89 | MAP3K7 | 0.69885287 |
90 | ALK | 0.69716454 |
91 | PLK2 | 0.67445346 |
92 | CAMK4 | 0.67349663 |
93 | CSF1R | 0.66534746 |
94 | PIK3CG | 0.65986374 |
95 | YES1 | 0.65950660 |
96 | PIM1 | 0.65640031 |
97 | FGR | 0.65259766 |
98 | PDGFRB | 0.63937983 |
99 | GRK5 | 0.63735676 |
100 | ZAP70 | 0.61163945 |
101 | RPS6KB1 | 0.60571850 |
102 | MAP2K3 | 0.60314819 |
103 | CDK12 | 0.59908327 |
104 | PDPK1 | 0.59207497 |
105 | RPS6KA3 | 0.58743880 |
106 | HCK | 0.58726656 |
107 | DYRK1A | 0.58194493 |
108 | MAPK10 | 0.58164173 |
109 | PTK2B | 0.58090635 |
110 | DMPK | 0.56854099 |
111 | SCYL2 | 0.56809131 |
112 | CAMK2B | 0.55972766 |
113 | RAF1 | 0.55813374 |
114 | FYN | 0.55297190 |
115 | FRK | 0.55195630 |
116 | UHMK1 | 0.54676562 |
117 | INSRR | 0.53999913 |
118 | CCNB1 | 0.53866333 |
119 | NEK9 | 0.53403627 |
120 | CSNK1G2 | 0.52869577 |
121 | MAP3K6 | 0.51575994 |
122 | CDK4 | 0.51327311 |
123 | PDGFRA | 0.49042288 |
124 | ACVR1B | 0.46419910 |
125 | SYK | 0.46351647 |
126 | PRKCQ | 0.45914598 |
127 | LMTK2 | 0.45368973 |
128 | CDK3 | 0.43861243 |
129 | PRKG1 | 0.43567039 |
130 | MAPK12 | 0.42423071 |
131 | PRKCE | 0.41861035 |
132 | PAK3 | 0.41404303 |
133 | MAPK8 | 0.40446221 |
134 | PRKCB | 0.40137588 |
135 | HIPK2 | 0.39038379 |
136 | PRKCZ | 0.38937097 |
137 | CDK9 | 0.38591469 |
138 | PRKD1 | 0.37639158 |
139 | RPS6KA2 | 0.37589125 |
140 | MAP3K14 | 0.37356166 |
141 | PKN1 | 0.36602626 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.02405347 |
2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.35694948 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.35099373 |
4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.27004231 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.24967565 |
6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.19311140 |
7 | Morphine addiction_Homo sapiens_hsa05032 | 2.16836385 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.99368848 |
9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.98040312 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.95860848 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 1.86304476 |
12 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75539507 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.72199492 |
14 | Renin secretion_Homo sapiens_hsa04924 | 1.70482646 |
15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.70034880 |
16 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.69724994 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 1.66423344 |
18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.59507288 |
19 | Taste transduction_Homo sapiens_hsa04742 | 1.59470641 |
20 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.56907298 |
21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.52960186 |
22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52552886 |
23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.51563565 |
24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42973222 |
25 | Long-term depression_Homo sapiens_hsa04730 | 1.42664373 |
26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42335951 |
27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39324257 |
28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35254547 |
29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.32625236 |
30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.31275042 |
31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30660624 |
32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29842578 |
33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29359570 |
34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.26874420 |
35 | Measles_Homo sapiens_hsa05162 | 1.25486206 |
36 | Glioma_Homo sapiens_hsa05214 | 1.22276103 |
37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.21044170 |
38 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.17073351 |
39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.14489359 |
40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14445273 |
41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13857181 |
42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07742396 |
43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05094258 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.04943049 |
45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04603701 |
46 | Allograft rejection_Homo sapiens_hsa05330 | 1.03205582 |
47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03000741 |
48 | Axon guidance_Homo sapiens_hsa04360 | 1.02397468 |
49 | Gap junction_Homo sapiens_hsa04540 | 1.02302378 |
50 | Tuberculosis_Homo sapiens_hsa05152 | 1.01459131 |
51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01141573 |
52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00286166 |
53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99861590 |
54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98541069 |
55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97689453 |
56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96439286 |
57 | Influenza A_Homo sapiens_hsa05164 | 0.95240204 |
58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93445053 |
59 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93256748 |
60 | Prostate cancer_Homo sapiens_hsa05215 | 0.92253008 |
61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91827911 |
62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.91699764 |
63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.91330611 |
64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89103955 |
65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88329791 |
66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87388189 |
67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87238024 |
68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85322727 |
69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85295957 |
70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85059424 |
71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85053037 |
72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84624433 |
73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84583581 |
74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84218885 |
75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82397619 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82093188 |
77 | Melanogenesis_Homo sapiens_hsa04916 | 0.81719677 |
78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79440827 |
79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78878666 |
80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76632319 |
81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76021369 |
82 | Hepatitis C_Homo sapiens_hsa05160 | 0.74611355 |
83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74159272 |
84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73088490 |
85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.73079776 |
86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73069485 |
87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72387084 |
88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71569813 |
89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71498353 |
90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71380552 |
91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70142748 |
92 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.70023775 |
93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69596814 |
94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68065584 |
95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67634795 |
96 | Lysine degradation_Homo sapiens_hsa00310 | 0.66100369 |
97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65640866 |
98 | Platelet activation_Homo sapiens_hsa04611 | 0.65262804 |
99 | Phototransduction_Homo sapiens_hsa04744 | 0.65032144 |
100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64981831 |
101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64919384 |
102 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64150436 |
103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63777843 |
104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62941040 |
105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61910287 |
106 | Apoptosis_Homo sapiens_hsa04210 | 0.60882739 |
107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59750559 |
108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59471626 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59142107 |
110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58669727 |
111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58335635 |
112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57701192 |
113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57419366 |
114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55309106 |
115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53131301 |
116 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53094317 |
117 | Endocytosis_Homo sapiens_hsa04144 | 0.52213577 |
118 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50727552 |
119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50392027 |
120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48093284 |
121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47486996 |
122 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46823507 |
123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45560491 |
124 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42434615 |
125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42397512 |
126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42038934 |
127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41732365 |
128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41723118 |
129 | Insulin resistance_Homo sapiens_hsa04931 | 0.41195543 |